These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2208103)

  • 1. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review.
    Waxman DJ
    Cancer Res; 1990 Oct; 50(20):6449-54. PubMed ID: 2208103
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance associated with the glutathione system].
    Gouyette A
    Bull Cancer; 1994 Dec; 81 Suppl 2():69s-73s. PubMed ID: 7727862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
    Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modulation of alkylating agents.
    Frei E
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):22-4. PubMed ID: 1664143
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glutathione S transferases-pi].
    Takahashi Y; Niitsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-cancer drug resistance and glutathione S-transferases].
    Sato K; Tsuchida S; Tamai K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):592-8. PubMed ID: 2650631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
    Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG
    Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA; van Ommen B; van Bladeren PJ
    Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell biological markers of drug resistance in ovarian carcinoma.
    van der Zee AG; Hollema HH; de Bruijn HW; Willemse PH; Boonstra H; Mulder NH; Aalders JG; de Vries EG
    Gynecol Oncol; 1995 Aug; 58(2):165-78. PubMed ID: 7622101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic mechanisms of resistance to alkylating agents in tumor cells and normal tissues.
    Colvin M; Russo JE; Hilton J; Dulik DM; Fenselau C
    Adv Enzyme Regul; 1988; 27():211-21. PubMed ID: 3074628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.
    He N; Singhal SS; Awasthi S; Zhao T; Boor PJ
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):177-85. PubMed ID: 10406932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione-associated enzymes in anticancer drug resistance.
    Tew KD
    Cancer Res; 1994 Aug; 54(16):4313-20. PubMed ID: 8044778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.
    Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B
    Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glutathione in cellular resistance to alkylating agents.
    Colvin OM; Friedman HS; Gamcsik MP; Fenselau C; Hilton J
    Adv Enzyme Regul; 1993; 33():19-26. PubMed ID: 8356908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis.
    Schecter RL; Alaoui-Jamali MA; Batist G
    Biochem Cell Biol; 1992 May; 70(5):349-53. PubMed ID: 1353967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antitumor alkylating agents (AA).
    Teicher BA; Frei E
    Cancer Treat Res; 1991; 57():261-95. PubMed ID: 1686721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.